Deedwania, P C <br/><br/>
Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Jan 2016 
 - 56-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12581  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticholesteremic Agents--administration & dosage<br/>Atorvastatin--administration & dosage<br/>Blood Glucose--analysis<br/>Body Mass Index<br/>Cardiovascular Diseases--etiology<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Fasting--blood<br/>Female<br/>Humans<br/>Hypertension--complications<br/>Male<br/>Metabolic Syndrome--blood<br/>Middle Aged<br/>Predictive Value of Tests<br/>Risk Factors<br/>Triglycerides--blood